background image

Paid Clinical Trials South Dakota

Discover 274 paid clinical trials in South Dakota. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1
Active & Responsive

Helix Research Network

for
Genetic Predisposition to Disease, Genetics Disease
Location: Bethlehem PA, York PA, Raleigh NC, Rochester NY,
Sponsor: Helix, Inc

Sex: All

Age: 18+

Code: NCT06057181

Recruiting
Active & Responsive

Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)

for
Overactive Bladder (OAB)
Location: Owings Mills MD, West Columbia SC, Barrington IL,
Sponsor: FemPulse Corporation

Sex: Female

Age: 21+

Code: NCT07195656

Recruiting
Active & Responsive

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

for
Lung Cancer Diagnosis
Location: Hyannis MA, Stamford CT, Mullica Hill NJ,
Sponsor: Freenome Holdings Inc.

Sex: All

Age: 50+

Code: NCT06122077

Recruiting
Active & Responsive

Evaluating Patient Reported Outcomes and Surgeon Satisfaction With Ziplyft™

for
Blepharoplasty
Location: Kingston PA, Miami FL, Kenosha WI, Alexandria MN,
Sponsor: Osheru Inc.

Sex: All

Age: 35+

Code: NCT07144761

Recruiting
Active & Responsive

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

for
Rare Disorders, Undiagnosed Disorders,
Location: Sioux Falls SD
Sponsor: Sanford Health

Sex: All

Age: 0+

Code: NCT01793168

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

for
Diabetes Mellitus, Type 2, Hypertension,
Location: Halifax, Moncton, Malden MA, Methuen MA, Hamden CT,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT07064473

Phase3, Recruiting
Active & Responsive

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

for
PIK3CA Mutation, HER2- Negative Breast Cancer,
Location: Boston MA, New Haven CT, New York NY, Hackensack NJ,
Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06982521

Phase3, Recruiting
Active & Responsive

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

for
Ulcerative Colitis
Location: Providence RI, New York NY, Montreal, Chevy Chase MD,
Sponsor: Takeda

Sex: All

Age: 18 - 65

Code: NCT06095128

Recruiting
Active & Responsive

Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer

for
Endometrial Cancer
Location: New York NY, Albany NY, Doylestown PA, Brandywine MD,
Sponsor: Faeth Therapeutics

Sex: Female

Age: 18+

Code: NCT06463028

Phase2, Recruiting
Active & Responsive

Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009)

for
Non-small Cell Lung Cancer (NSCLC)
Location: Stony Brook NY, East Brunswick NJ, Montreal, Toronto,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06305754

Phase3, Recruiting

Popular cities in South Dakota

AberdeenSioux FallsRapid City